Company / Free Cash Flow per Share
BioLife Solutions, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.22
FY2025
5-year range
-$0.44 / $0.22
FY2021-FY2025
Trend
+93.6%
vs FY2024
Sector context
#106 of 142
Health Care
What the data says
BioLife Solutions, Inc.'s free cash flow per share of $0.22 is lower than 75% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has increased for 3 consecutive years, from $-0.44 in FY2022 to $0.22 in FY2025.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of +5.0%.
Improved from $-0.43 to $0.22 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 142This company $0.22 Sector average $5.16
▼
-95.8% below sector average
Key checks
Key Insights
- BioLife Solutions, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 93.6% year-over-year.
- Ranks #106 out of 142 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | +93.6% |
| FY2024 | $0.11 | +126.2% |
| FY2023 | -$0.43 | +1.4% |
| FY2022 | -$0.44 | -30.0% |
| FY2021 | -$0.34 | -296.5% |
| FY2020 | $0.17 | +520.5% |
| FY2019 | $0.03 | +15.3% |
| FY2018 | $0.02 | -33.1% |
| FY2017 | $0.04 | +110.0% |
| FY2016 | -$0.36 | +15.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026